Using ChatGPT to address vaccine hesitancy: a promising tool for guiding users to scientific information?

In a recent study published in Human Vaccines & Immunotherapeutics, a group of researchers assessed Chat Generative Pre-trained Transformer (GPT)’s ability to address the 50 most common misconceptions about vaccine safety and evaluate its alignment with established scientific evidence. Background In 2019, the World Health Organization (WHO) identified vaccine hesitancy, intensified by misinformation on social media, as a top global health threat. This hesitancy risks undoing the strides made against vaccine-preventable diseases. Particularly in Europe, confidence in vaccines was notably low in 2016. ChatGPT, OpenAI’s artificial intelligence (AI)-driven chatbot, offers interactive responses using advanced language processing. Despite its utility, there are concerns about its misuse, especially academically, prompting regulatory measures. Its wide accessibility also raises concerns about potential misuse in educational contexts. The WHO’s Vaccine Safety branch in Spain combats vaccination myths and misinformation. Given these circumstances, ChatGPT’s accuracy on Coronavirus Disease 2019 (COVID-19) vaccine safety information needs evaluation. About the study The researchers aimed to evaluate...